Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment-Experienced Patients.
Autorzy:
Schafer JJ; Department of Pharmacy Practice, Jefferson College of Pharmacy, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Pandit NS; Department of Pharmacy Practice and Science, University of Maryland Baltimore School of Pharmacy, Baltimore, Maryland, USA. Cha A; Brooklyn Hospital Center, Brooklyn, New York, USA. Huesgen E; Department of Pharmacy Practice, Indiana University Health, Indianapolis, Indianapolis, USA. Badowski M; Section of Infectious Diseases Pharmacotherapy, Department of Pharmacy Practice, University of Illinois at Chicago, College of Pharmacy, Chicago, Illinois, USA. Sherman EM; Department of Pharmacy Practice, College of Pharmacy, Nova Southeastern University, Fort Lauderdale, Florida, USA.; Division of Infectious Diseases, Memorial Healthcare System, Hollywood, Florida, USA. Cocohoba J; Department of Clinical Pharmacy, University of California San Francisco School of Pharmacy, San Francisco, California, USA. Shimada A; Division of Biostatistics, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Keith SW; Division of Biostatistics, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Dec 18; Vol. 8 (1), pp. ofaa625. Date of Electronic Publication: 2020 Dec 18 (Print Publication: 2021).
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies